Loading...
Market
Kobayashi action after investigation by Oct 31
4
Resolution / Starting Odds
Product recall • 33%
Product reformulation • 33%
No action taken • 33%
Official announcements from Kobayashi Pharmaceutical
Story
Kobayashi Pharmaceutical in Japan Investigates 76 Deaths Linked to Red Yeast Supplements
Jun 28, 2024, 06:30 AM
Kobayashi Pharmaceutical is currently investigating the potential link between its dietary supplements containing 'Beni-Koji' red yeast and 76 additional deaths. This investigation follows reports from the Japan Health Minister and various news outlets, including Nikkei and Reuters. The company is looking into whether these deaths are connected to the ingestion of their red yeast health supplements, a toll higher than initially reported. The investigation was announced on Friday in Japan.
View original story
Similar markets
Russian pilot at fault • 25%
US pilot at fault • 25%
Both pilots at fault • 25%
Inconclusive • 25%
Further apologies • 25%
Compensation to China • 25%
Military policy changes • 25%
No further action • 25%
Suicide confirmed • 25%
Homicide confirmed • 25%
Accidental death • 25%
Inconclusive • 25%
Formal protest • 25%
Diplomatic talks • 25%
No action • 25%
Economic sanctions • 25%
No Action Taken • 25%
Warning Issued • 25%
Disciplinary Action • 25%
Other • 25%
Conviction and prison sentence • 25%
Conviction and suspended sentence • 25%
Acquittal • 25%
Case dropped • 25%
Conclusions Announced • 50%
No Conclusions Announced • 50%
Resumes DPP leadership • 25%
Steps down permanently • 25%
Joins another party • 25%
Retires from politics • 25%
Yes • 50%
No • 50%
Major reforms implemented • 25%
Minor adjustments made • 25%
No changes • 25%
Investigation ongoing • 25%
Shooting deemed justified • 25%
Shooting deemed unjustified • 25%
No conclusive outcome • 25%
Other • 25%
No wrongdoing found • 25%
Minor violations found • 25%
Major violations found • 25%
Investigation inconclusive • 25%